The Pharmaceutical Glass Packaging Market - Growth, Trends, and Future Outlook

Market Definition

According to Next Move Strategy Consulting, the Pharmaceutical Glass Packaging Market and is predicted to reach USD 39 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10% by 2030. Pharmaceutical glass packaging is widely regarded as a sustainable and eco-friendly option for storing strong alkalis and acids, offering excellent resistance to temperature fluctuations and atmospheric gases. The materials used in pharmaceutical glass include silica, boric oxide, sodium oxide, and aluminum oxide, ensuring the stability of the drug by preventing the escape of volatile ingredients and minimizing contamination risks. Due to its durability, impermeability, and recyclability, pharmaceutical glass packaging is the preferred choice for safeguarding drugs during bulk transportation and storage.

Click Here for Your FREE Sample!

Market Dynamics and Trends

1. Rising Demand in the Pharmaceutical Industry

The growing prevalence of chronic diseases is one of the key drivers fueling the demand for pharmaceutical glass packaging. Diseases such as cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes are increasing globally, leading to a greater need for medicines and healthcare products. This surge in demand is directly contributing to the growth of the pharmaceutical glass packaging market. According to the World Health Organization (WHO), cardiovascular diseases accounted for 17.9 million deaths in 2021, followed by cancer-related deaths at 9.3 million. These statistics emphasize the need for reliable pharmaceutical packaging solutions.

2. Technological Advancements in Packaging

Advancements in technology have significantly impacted the pharmaceutical glass packaging market. The development of moisture and air-proof boron-free glass, along with innovations like radiofrequency identification (RFID) technology and child-resistant packaging, are enhancing safety, efficiency, and convenience. These innovations aim to address the evolving needs of the pharmaceutical industry, improving packaging quality while ensuring the safety of products. In 2022, Bormioli Pharma collaborated with the Italian research center IMEM-CNR to develop advanced coatings that enhance the performance of glass bottles, making them more resilient to hostile pharmaceutical formulations.

3. Challenges and Opportunities

The pharmaceutical glass packaging market faces challenges, including the availability of cheaper plastic alternatives that could hinder the adoption of glass packaging. However, emerging technologies such as 3D printing and advancements in sustainable materials, like bio-based and recycled glass, present new opportunities for market expansion. These technologies allow for more flexible, customized manufacturing processes, offering innovative solutions for packaging designs suited to specific pharmaceutical products.

Market Segmentation and Scope of Study

The pharmaceutical glass packaging market is segmented based on material, product type, drug type, and region.

• By Material: The market is divided into Type I, Type II, and Type III glass.
• By Product: Pharmaceutical glass packaging includes Ampoules, Bottles, Vials, Syringes, and Cartridges.
• By Drug Type: The market is segmented into Generic, Branded, and Biologic drugs.
• By Region: The market is analyzed across North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Geographical Analysis

1. North America

North America currently holds the dominant share in the pharmaceutical glass packaging market, with expectations of continued growth. The region’s increasing prevalence of chronic diseases is driving the demand for pharmaceutical packaging solutions. According to the Centers for Disease Control and Prevention (CDC), over 133 million Americans suffer from at least one chronic disease, highlighting the growing need for pharmaceutical products. Moreover, major players like Owens Illinois Inc., Ardagh Packaging Group, Stevanato Group, and Piramal Glass Limited have a strong presence in the region. In 2022, Gerresheimer, a major pharmaceutical packaging supplier, announced a USD 94 million investment to expand its glass vial production capabilities in the U.S.

2. Asia-Pacific

Asia-Pacific is poised to experience steady growth in the pharmaceutical glass packaging market due to the rapidly expanding population and the increasing prevalence of chronic diseases. The region’s population, accounting for over 50% of the global total, is expected to drive significant demand for pharmaceutical products. India and China, with populations of 1.44 billion and 1.41 billion, respectively, represent vast markets for pharmaceutical products. Furthermore, the robust growth of the pharmaceutical industry in countries like China, which accounts for over 30% of global pharmaceutical production, is expected to propel demand for pharmaceutical glass packaging in the region.

Competitive Landscape

The pharmaceutical glass packaging market is highly competitive, with numerous global and regional players. Key companies in the market include Ardagh Group S.A., Bormioli Pharma S.R.L., Piramal Glass Private Limited, Schott AG, Sisecam, Owens-Illinois Inc., Amcor Limited, Gerresheimer AG, West Pharmaceutical Services Inc., and Nipro Corporation. These players are adopting strategies such as acquisitions, partnerships, and technological advancements to maintain their dominance in the market.

For instance, in October 2022, Nipro Corporation expanded its presence in the Philippines by establishing a medical device sales subsidiary to strengthen its distribution network. In January 2022, West Pharmaceutical Services entered into an exclusive supply and technology agreement with Corning Incorporated to extend the use of Corning’s Valor Glass technology for advanced packaging solutions for injectable medicines.

Download Free Sample

Key Benefits

• The report provides quantitative analysis and forecasts for the pharmaceutical glass packaging market from 2024 to 2030, offering valuable insights into market opportunities.
• It includes a comprehensive analysis of the current and future trends in the pharmaceutical glass packaging market, highlighting potential investment opportunities.
• Detailed information on the key drivers, restraints, and opportunities impacting the market is provided, along with their effects on growth.
• The report includes a competitive analysis of key market players and their market shares.
• SWOT analysis and Porter’s Five Forces model are used to evaluate market dynamics.
• The value chain analysis offers a clear view of stakeholder roles within the pharmaceutical glass packaging industry.

Key Market Segments

• By Material: Type I, Type II, and Type III glass.
• By Product: Ampoules, Bottles, Vials, Syringes, and Cartridges.
• By Drug Type: Generic, Branded, and Biologic.
• By Region: North America, Europe, Asia-Pacific, and the Rest of the World.

Market Outlook

The pharmaceutical glass packaging market is expected to experience substantial growth, driven by increasing demand for medicines, technological advancements in packaging, and the expanding prevalence of chronic diseases. However, the market may face challenges from plastic alternatives, which could limit the adoption of glass packaging. Despite this, the emergence of 3D printing and sustainable glass materials offers exciting opportunities for growth and innovation in the packaging industry.

With the increasing focus on sustainability and the need for customized packaging solutions, the pharmaceutical glass packaging market is poised to expand, meeting the evolving needs of the pharmaceutical industry.

Conclusion

The pharmaceutical glass packaging market is on track for significant growth, with advancements in technology, rising demand for pharmaceutical products, and an increasing focus on sustainability. The North American and Asia-Pacific regions are expected to lead the market, driven by demographic factors and the expanding pharmaceutical industry. As the market continues to evolve, players in the pharmaceutical glass packaging industry are well-positioned to capitalize on emerging opportunities, such as 3D printing and sustainable materials, ensuring continued market expansion through 2030 and beyond.

About Next Move Strategy Consulting:

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations within dustry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses

Summary

Glass packaging is preferred in the pharmaceutical industry due to its sustainability, durability, and ability to preserve drug stability by preventing contamination and volatile ingredient loss.

Key drivers include the rising prevalence of chronic diseases, advancements in packaging technologies such as moisture-proof and air-proof glass, and innovations like child-resistant and RFID-enabled packaging. However, the availability of cheaper plastic alternatives poses a challenge. Opportunities lie in emerging technologies like 3D printing and the use of bio-based or recycled glass materials.